P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS

Bibliographic Details
Main Authors:	Bauche C, Souque P, Caleechurn L, Boulay A, Coutant F, Riviere J, Munier S, Liard C, Mollier K, Beignon A, Charneau P
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria.
by: Frédéric Coutant, et al.
Published: (2012-01-01)

Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.
by: Frédéric Coutant, et al.
Published: (2008-01-01)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
by: Blasi M, et al.
Published: (2012-09-01)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
by: Negri Donatella RM, et al.
Published: (2012-08-01)

Lentiviral vector induces high-quality memory T cells via dendritic cells transduction
by: Min Wen Ku, et al.
Published: (2021-06-01)

Mapping the small RNA content of simian immunodeficiency virions (SIV).
by: Markus Brameier, et al.
Published: (2013-01-01)

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors
by: Strasak Alexander, et al.
Published: (2009-06-01)

A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.
by: Mélissanne de Wispelaere, et al.
Published: (2015-01-01)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

High Rate of Simian Immunodeficiency Virus (SIV) Infections in Wild Chimpanzees in Northeastern Gabon
by: Vanina Boué, et al.
Published: (2015-09-01)

Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
by: Kumudhini Preethi Haran, et al.
Published: (2018-03-01)

Hippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV)
by: Heather Carryl, et al.
Published: (2017-04-01)

Etude fonctionnelle du peptide de fusion du virus siv (Simian Immunodeficiency Virus)
by: Lambrecht, Bénédicte
Published: (1995)

Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques
by: Pahar Bapi, et al.
Published: (2012-08-01)

Production of lentiviral vectors
by: Otto-Wilhelm Merten, et al.
Published: (2016-01-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques
by: Y. Wu, et al.
Published: (2017-12-01)

Development and optimization of a simian immunodeficiency virus (SIV) droplet digital PCR (ddPCR) assay.
by: Samuel Long, et al.
Published: (2020-01-01)

The Inside Out of Lentiviral Vectors
by: Stéphanie Durand, et al.
Published: (2011-02-01)

STRATEGIES FOR TARGETING LENTIVIRAL VECTORS
by: Trimby, Christopher Matthew
Published: (2011)

Lentiviral vectors for gene therapy
by: Knight, S. B.
Published: (2012)

Lentiviral vectors for treatment of haemophilia
by: Ward, N. J.
Published: (2010)

Revisiting a quarter of a century of simian immunodeficiency virus (SIV)-associated cardiovascular diseases at the German Primate Center
by: M. Mietsch, et al.
Published: (2017-06-01)

Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels
by: Charneau Pierre, et al.
Published: (2006-06-01)

Proliferation of perivascular macrophages in macaque models of lentiviral encephalitis: a potential mechanism for HIV/SIV persistence in the brain
by: W.K. Kim, et al.
Published: (2015-12-01)

Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy
by: Greenhouse Jack, et al.
Published: (2010-03-01)

Influence of Naturally Occurring Simian Foamy Viruses (SFVs) on SIV Disease Progression in the Rhesus Macaque (Macaca mulatta) Model
by: Joel Beren, et al.
Published: (2013-06-01)

Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline.
by: Julia L Drewes, et al.
Published: (2014-01-01)

Simian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral Infections.
by: Edward J D Greenwood, et al.
Published: (2015-09-01)

An Improved Protocol for the Production of Lentiviral Vectors
by: Logan Y. Brown, et al.
Published: (2020-12-01)

Comparison of lentiviral vector titration methods
by: Debyser Zeger, et al.
Published: (2006-07-01)

Rev-dependent lentiviral expression vector
by: Beddall Margaret H, et al.
Published: (2007-02-01)

Lentiviral vectors as tools for gene manipulation
by: Godfrey, Andrew Robert
Published: (2006)

Simian virus 40 vectors for pulmonary gene therapy
by: Oppenheim Ariella, et al.
Published: (2007-10-01)

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) <it>in vitro </it>and Simian Immunodeficiency virus (SIV) <it>ex vivo</it>
by: Borojerdi Jennifer P, et al.
Published: (2009-11-01)

Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage
by: Caldwell Maeve, et al.
Published: (2005-09-01)

Development of a novel simian adenovirus 24 based vaccine vector
by: Abbink P, et al.
Published: (2012-09-01)

Epitope specificity appears to be an important determinant of in vivo killing ability of simian immunodeficiency virus (SIV)-specific CD8+ T Cells
by: Pozzi L, et al.
Published: (2012-09-01)

Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART).
by: Benjamin Bruno Policicchio, et al.
Published: (2018-01-01)

The feasibility of incorporating Vpx into lentiviral gene therapy vectors
by: Samantha A McAllery, et al.
Published: (2016-01-01)